Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation
Clinical trial NCT01251952 · TERMINATED
Trial details
- NCT number
- NCT01251952
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.